Donald Notman
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Donald Notman is Chief Operating Officer at Ocular Therapeutix, Inc. since 2026.
Formerly, Mr. Notman was Managing Director & Head-Private Capital Markets at Leerink Partners LLC.
From 2014 to 2017, Mr. Notman was Chief Financial Officer & Senior Vice President at Thrasos Therapeutics, Inc. Education includes an undergraduate degree from Middlebury College and an MBA from Tuck School of Business at Dartmouth.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OCULAR THERAPEUTIX INC 0,09 % | 31/03/2026 | 184.662 ( 0,09 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Director de Operaciones | 29/08/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Director Financiero/CFO | 01/03/2017 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.